Cargando…

Animal models to study the neurological manifestations of the post-COVID-19 condition

More than 40% of individuals infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have experienced persistent or relapsing multi-systemic symptoms months after the onset of coronavirus disease 2019 (COVID-19). This post-COVID-19 condition (PCC) has debilitating effects on the dai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Usai, Carla, Mateu, Lourdes, Brander, Christian, Vergara-Alert, Júlia, Segalés, Joaquim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462483/ https://www.ncbi.nlm.nih.gov/pubmed/37620562 http://dx.doi.org/10.1038/s41684-023-01231-z

Ejemplares similares

Searching for animal models and potential target species for emerging pathogens: Experience gained from Middle East respiratory syndrome (MERS) coronavirus
por: Vergara-Alert, Júlia, et al.
Publicado: (2017)

Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target
por: Veljkovic, Veljko, et al.
Publicado: (2021)

Lifting the mask on neurological manifestations of COVID-19
por: Pezzini, Alessandro, et al.
Publicado: (2020)

Enhanced antiviral immunity and dampened inflammation in llama lymph nodes upon MERS-CoV sensing: bridging innate and adaptive cellular immune responses in camelid reservoirs
por: Rodon, Jordi, et al.
Publicado: (2023)

Evaluation of alpaca tracheal explants as an ex vivo model for the study of Middle East respiratory syndrome coronavirus (MERS-CoV) infection
por: Te, Nigeer, et al.
Publicado: (2022)

Enhanced replication fitness of MERS-CoV clade B over clade A strains in camelids explains the dominance of clade B strains in the Arabian Peninsula
por: Te, Nigeer, et al.
Publicado: (2021)

An animal model manifesting neurodegeneration and obesity
por: Susaki, Etsuo, et al.
Publicado: (2010)

Therapeutic Approaches to the Neurologic Manifestations of COVID-19
por: Graham, Edith L., et al.
Publicado: (2022)

Neurological and Psychiatric Manifestations of Post-COVID-19 Conditions
por: Jung, Young Hee, et al.
Publicado: (2023)

Neurological manifestations of COVID-19: A perspective from Pakistani medical students
por: Adil, Mariam, et al.
Publicado: (2022)

Agreement and differential use of laboratory methods for the detection and quantification of SARS-CoV-2 in experimentally infected animals
por: Usai, Carla, et al.
Publicado: (2022)

Clinical time course of COVID-19, its neurological manifestation and some thoughts on its management
por: Zhou, Yifan, et al.
Publicado: (2020)

Development of Different Animal Models for Middle East Respiratory Syndrome-Coronavirus (MERS-CoV) Infection
por: Vergara-Alert, J., et al.
Publicado: (2017)

Co‐localization of Middle East respiratory syndrome coronavirus (MERS‐CoV) and dipeptidyl peptidase‐4 in the respiratory tract and lymphoid tissues of pigs and llamas
por: Te, Nigeer, et al.
Publicado: (2018)

Type I and III IFNs produced by the nasal epithelia and dimmed inflammation are features of alpacas resolving MERS-CoV infection
por: Te, Nigeer, et al.
Publicado: (2021)

The Potential Role of Hypothalamic Phospholipid Liposomes in the Supportive Therapy of Some Manifestations of Post-COVID-19 Condition: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Brain Fog
por: Menichetti, Francesco
Publicado: (2023)

Role of formyl peptide receptor 2 (FPR2) in the normal brain and in neurological conditions
por: Ong, Wei-Yi, et al.
Publicado: (2019)

Towards a universal understanding of post COVID-19 condition
por: Diaz, Janet V, et al.
Publicado: (2021)

Neurological Dysfunction in Long COVID Should Not Be Labelled as Functional Neurological Disorder
por: Van der Feltz-Cornelis, Christina M., et al.
Publicado: (2023)

Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen
por: Rodon, Jordi, et al.
Publicado: (2021)

Continued development of azithromycin as a neuroprotective therapeutic for the treatment of spinal cord injury and other neurological conditions
por: Kopper, Timothy J., et al.
Publicado: (2020)

Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection
por: Pradenas, Edwards, et al.
Publicado: (2022)

Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19
por: Pantelis, Christos, et al.
Publicado: (2020)

Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
por: Díez, José María, et al.
Publicado: (2020)

Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein
por: Rodon, Jordi, et al.
Publicado: (2019)

Heterologous Systemic Prime–Intranasal Boosting Using a Spore SARS-CoV-2 Vaccine Confers Mucosal Immunity and Cross-Reactive Antibodies in Mice as well as Protection in Hamsters
por: Katsande, Paidamoyo M., et al.
Publicado: (2022)

Pesticides and Neurologic Symptoms
por: Burns, Carol, et al.
Publicado: (2005)

Role of animal models in glaucoma research
por: Kimura, Atsuko, et al.
Publicado: (2020)

Neurological manifestations of post-COVID-19 syndrome S1-guideline of the German society of neurology
por: Franke, Christiana, et al.
Publicado: (2022)

Animal Models Are Valid to Uncover Disease Mechanisms
por: Wurst, Wolfgang
Publicado: (2016)

Conserved Synthetic Peptides from the Hemagglutinin of Influenza Viruses Induce Broad Humoral and T-Cell Responses in a Pig Model
por: Vergara-Alert, Júlia, et al.
Publicado: (2012)

Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
por: Pradenas, Edwards, et al.
Publicado: (2021)

Middle East respiratory syndrome coronavirus experimental transmission using a pig model
por: Vergara‐Alert, J., et al.
Publicado: (2017)

Implications of Withaferin A in neurological disorders
por: Ram, Natasha, et al.
Publicado: (2020)

Transcranial electrical stimulation in neurological disease
por: Brown, Gregory L., et al.
Publicado: (2022)

Repurposing niclosamide for the treatment of neurological disorders
por: Apolloni, Savina, et al.
Publicado: (2023)

COVID-19: a “black swan” and what animal breeding can learn from it
por: Simianer, Henner, et al.
Publicado: (2021)

COVID-19: Ocular Manifestations and the APAO Prevention Guidelines for Ophthalmic Practices
por: Wong, Raymond L.M., et al.
Publicado: (2020)

Pigs are not susceptible to SARS‐CoV‐2 infection but are a model for viral immunogenicity studies
por: Vergara‐Alert, Júlia, et al.
Publicado: (2020)

Conservation physiology of animal migration
por: Lennox, Robert J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_urodnc866fpfenmq3eufracrnu